Testing effectiveness (Phase 2)Study completedNCT02055638
What this trial is testing
Safety, Tolerability and Activity of SRX246 in Adults With Intermittent Explosive Disorder
Who this might be right for
Intermittent Explosive Disorder
Azevan Pharmaceuticals 97